Upstream Bio, Inc. (UPB) — 10-K Filings
All 10-K filings from Upstream Bio, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Upstream Bio's Verekitug Shows Promise in Phase 2, Targets $8B+ Market
— Mar 26, 2026 Risk: high
Upstream Bio, Inc. (UPB) is a clinical-stage biotechnology company focused on inflammatory diseases, particularly severe respiratory disorders. The company is d - 10-K Filing — Mar 12, 2025
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX